Masimo and Vera Therapeutics Stock See Action From Activist Investors

Politan Capital won two seats on the board of monitoring-tech firm Masimo. Carlyle Group cut its stake in pharmaceuticals firm Vera.

Related Keywords

United States ,China ,American ,Chinese ,Mueller Industrie ,Quentin Koffey ,Michelle Brennan ,Abingworth Bioventures ,Exchange Commission ,Mueller Industries ,Carlyle Group ,Politan Capital ,Vera Therapeutics ,Coliseum Capital ,Gamco Investors ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Biological Therapy ,Healthcare Provision ,Financial Performance ,Earnings ,Sales Figures ,Management ,Shareholder Activism ,Corporate Industrial News ,Corporate Governance ,Environmental Social Governance ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,13d Filings ,Activist Investing ,Biotech And Pharma ,Healthcare ,Manufacturing ,Technology ,Magazine ,Department ,Vera ,Gms ,Masimo ,Masi ,Gimli ,I Mab ,Himab ,Corporate ,Industrial News ,Environmental ,Social ,Governance ,Life Sciences ,